Related Experiment Video
Updated: Sep 10, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Risk factors for persistent hypertension in primary aldosteronism after surgery: a systematic review and
1Department of Internal Medicine-Cardiovascular, Xiang'an Branch, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
Introduction:
This systematic review and meta-analysis delved into the identification of risk factors associated with persistent hypertension in patients with primary aldosteronism (PA) following surgery.
Methods:
Through an exhaustive search across PubMed, Embase, and Cochrane Library databases, 12 studies meeting stringent inclusion criteria were scrutinized.
Results:
The analysis unveiled several significant risk factors contributing to postoperative hypertension persistence in PA patients. Notably, the duration of hypertension emerged as a pivotal predictor, suggesting a correlation between longer preoperative hypertension durations and heightened postoperative hypertension likelihood. Additionally, elevated body mass index (BMI) surfaced as another notable risk factor, accentuating the imperative of weight management interventions in optimizing surgical outcomes. Further, serum potassium levels and estimated glomerular filtration rate (eGFR) were discerned as crucial determinants of postoperative hypertension. Elevated serum potassium levels and diminished eGFR were associated with an augmented risk of persistent hypertension, underscoring the necessity of meticulous preoperative renal function assessment and electrolyte balance management.
Conclusion:
These findings underscore the paramount importance of preoperative risk assessment and tailored postoperative management strategies to enhance the prognosis and quality of life for PA patients undergoing surgery.
More Related Videos
Related Concept Videos
Hypertension II: Pathophysiology
Antihypertensive Drugs: Potassium-Sparing Diuretics
Hypertension and Regulation of Blood Pressure
Hormonal Regulation
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors

